Dear Voornaam
The first HPV vaccination was introduced in 2006. More than a decade later, a long-awaited study published in The Lancet showed a dramatic reduction in cervical cancer rates among HPV vaccinated women, proving the effectiveness of a health service to eliminate one of the most common causes of death of women worldwide.
Yesterday at the Early Detection of Cancer conference, we proudly unveiled the winner of the Don Listwin Award, Peter Sasieni, the lead author of that study and Director of the Cancer Research UK Prevention Trials Unit at Queen Mary University of London.
Fresh from his award presentation, we spoke to Peter on the story behind HPV vaccination, the opportunities and challenges for cancer prevention research and the promise of multi-cancer early detection tests.
I was also delighted to greet all the great minds presenting at the conference, each making exemplary contributions to the cancer early detection fields and inspiring us all. Together with Canary Center at Stanford and OHSU Knight Cancer Institute, were accelerating research so that cancers can be diagnosed and treated at the earliest stage.
See you in the US next year
Kind regards,
Dr Iain Foulkes Executive Director Research & Innovation CEO Cancer Research Horizons Cancer Research UK |
|
---|
|
---|
|
|
Funding & Research Opportunities |
|
---|
|
---|
| Applications accepted all-year round |
|
---|
|
---|
| Applications accepted all-year round |
|
---|
|
---|
| Applications accepted all-year round |
|
---|
|
---|
|
|
APPLICATIONS OPEN FOR BLACK LEADERS IN CANCER PHD PROGRAMME Our Black Leaders in Cancer PhD scholarship programme is now live for the 2023 application cycle.
This programme, run in partnership with Black in Cancer and the Windsor Fellowship offers four students from Black heritage backgrounds the opportunity of a four-year fully funded PhD at either our City of London or our Cambridge centre. Theyll also have access to support and mentorship throughout their placement.
Spread the word in your network applications due 9 November for City of London Centre and 15 November for the Cambridge Centre. |
|
---|
|
---|
|
|
NEW DATE IN DATA WEBINAR SERIES: MAKING DATA FAIR Join us on 27 November for Making Data FAIR, the second event in our webinar series on all things research data. This time, we'll be covering how to ensure your data is findable, accessible, interoperable and reproducible (FAIR).
Youll hear from data experts Kevin Litchfield (The Francis Crick Institute), Joseph Day (Cancer Research Horizons) and Kasia Kamieniecka (ELIXIR-UK) on how to maximise the usefulness of your datasets, as well as insights from experts in data sharing tools and platforms.
Youll also have the chance to ask your questions about applying the FAIR principles in practice. |
|
---|
| APPLY TO THE CRICKS FULLY FUNDED PHD FOR CLINICIANS PROGRAMME Are you a clinician with a passion for research? Apply for the Francis Crick Institutes three-year fully funded doctoral fellowships for clinicians to gain a broad and deep interdisciplinary research experience.
This opportunity allows you to perform biomedical discovery research while following the Cricks PhD programme. You will be based at the Crick, with a Crick primary supervisor and a secondary supervisor from one of the Crick partner universities: Imperial College London, Kings College London and UCL.
Find out more about eligibility and how to apply. Applications due 15 November. |
|
---|
|
---|
|
|
NEW WORKSHOP ON TACKLING DRUG RESISTANCE IN CANCER Catch us at Hilton York on 31 January 2024 for the chance to help tackle the big questions around drug resistance in cancer.
Our new workshop in partnership with Physics of Life and the Rosetrees Trust is bringing together clinicians and researchers from various fields to explore the pathways of tumour resistance from mechanisms to translation.
You will hear from Ben OLeary (The Institute of Cancer Research and The Royal Marsden), Maria Secrier (UCL Genetics Institute), Alexander Anderson (Moffitt Cancer Centre), Ross Cagan (University of Glasgow), Bartek Waclaw (University of Edinburgh), Xiao Fu (Cancer Research UK Scotland Institute), Chris Twelves (NIHR Leeds Clinical Research Facility), Tim Eisen (University of Cambridge and Roche Product Development), Samra Turajlic (The Royal Marsden, The Francis Crick Institute and The Institute of Cancer Research) among many others.
Sign up now to join the conversation. |
|
---|
|
---|
|
|
JOIN OUR WORK IN EARLY DETECTION AND DIAGNOSIS Were looking to recruit a Chief Medical Officer to assist the development of a proposal for our Cancer Data Driven Detection initiative.
This is a proposed national research programme dedicated to using data to revolutionise our understanding of cancer risk and allow the early detection of cancers.
If youre a clinical scientist with a proven reputation for excellence, please consider joining our cutting-edge initiative and enable future translation into patient benefit. |
|
---|
| MAXIMISE THE IMPACT OF YOUR CANCER RESEARCH UK-FUNDED DATA Are you seeking funding for your data-powered research? If youre a researcher funded by us, the Data Innovation Awards offered by our innovation arm Cancer Research Horizons can provide you with up to 75,000 funding to support data cleaning, annotation, curation, linking and storage.
We will also help you establish a long-term data sharing strategy and audit the patient consent and background agreement situation to ensure theyre able to work with you to share the data through commercial data partnerships.
Find out more about eligibility and how to get involved. |
|
---|
|
---|
|
|
| Liverpool, UK 18 October 2023 |
|
---|
|
---|
| Cambridge, UK 20 October 2023 |
|
---|
|
---|
| Cambridge, UK 03 November 2023 |
|
---|
|
---|
| Edinburgh, UK 14 November 2023 |
|
---|
|
---|
| London, UK 14 November 2023 |
|
---|
|
---|
| London, UK 21 November 2023 |
|
---|
|
---|
| Manchester, UK 27 February 2024 |
|
---|
|
---|
|
|
WHAT DID YOU THINK OF THIS EMAIL? We're always looking for ways to improve. Please give us your feedback by clicking below and leaving a comment. |
|
---|
|
---|
|
|
Been forwarded this email? Subscribe to our newsletter to stay up-to-date. |
---|
| |
---|
|
|
|